Liki24
Financials
Estimates*
EUR | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | <1m | <1m | 1.2m | <1m | 1.1m |
% growth | - | 925 % | 55 % | (18 %) | 7 % |
Profit | (<1m) | <1m | (1.2m) | <1m | - |
% profit margin | (55 %) | 7 % | (99 %) | 25 % | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
$1.0m | Series A | ||
* | $1.0m | Seed | |
$5.0m | Early VC | ||
N/A | Series A | ||
* | N/A | Early VC | |
$100k | Support Program | ||
$1.0m | Seed | ||
Total Funding | $8.1m |
Related Content
Recent News about Liki24
EditLiki24.com operates as a healthcare delivery platform that bridges the gap between pharmacies and customers, ensuring fast and reliable medication delivery. The company primarily serves individuals who require timely access to medications, including prescription drugs, over-the-counter products, and health-related items. Operating in the healthcare and logistics market, Liki24.com leverages a network of partner pharmacies and a fleet of couriers to fulfill customer orders efficiently.
The business model revolves around aggregating products from various pharmacies and offering them through a user-friendly online platform. Customers can place orders via the website or mobile app, and Liki24.com coordinates the procurement and delivery process. Revenue is generated through service fees charged to customers for delivery and through partnerships with pharmacies that benefit from increased sales and customer reach.
Liki24.com stands out by providing a seamless and convenient solution for medication delivery, addressing the needs of customers who may have mobility issues, time constraints, or prefer the convenience of home delivery. The platform also offers price comparisons, helping customers find the best deals on their medications.
Keywords: healthcare delivery, medication, pharmacies, logistics, online platform, prescription drugs, over-the-counter, couriers, price comparison, customer convenience.